Imvax | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Trial results

2 December 2025

Imvax’s brain fail

But the group still hopes to get IGV-001 approved based on overall survival data.

Subscribe to Imvax